At a Glance
Eurazeo is one of Europe's leading investment firms, founded in 1969 and headquartered in Paris. Originally established as a publicly traded investment company, Eurazeo has evolved into a comprehensive investment platform managing over €30 billion across private equity, venture capital, and growth investments. The firm operates through several specialized divisions including Eurazeo Ventures for early-stage investments, Eurazeo Growth for scaling companies, and traditional buyout activities. Under CEO Virginie Morgon's leadership since 2018, Eurazeo has significantly expanded its venture and growth activities while maintaining its strong European roots. The firm is known for its hands-on approach to portfolio development and has built a reputation for backing category-defining companies across technology, digital health, fintech, and consumer sectors. Eurazeo's public listing provides transparency and allows it to take a long-term view on investments, differentiating it from traditional private equity models.
“Invests in companies creating sustainable growth across technology, healthcare, and consumer sectors, from venture to buyout.”
Eurazeo primarily invests at the Seed, Series A, Series B+ stages. This means they focus on companies that are building their initial product and finding product-market fit.
Eurazeo is headquartered in Paris, France. Many of their portfolio companies are also based in this region, though they invest across geographies.
Eurazeo focuses on investments in Enterprise, Consumer, Digital Health, Fintech, Climate. Their portfolio reflects deep expertise and networks within these sectors.
Eurazeo's typical investment check size ranges from $1M to $200M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Eurazeo manages approximately $35B in assets under management (AUM) across their funds.